Consumer telehealth · Weight-loss compounding
Henry Meds
Henry Meds is a direct-to-consumer telehealth company focused on compounded weight-loss and related medication programs. Patients get online clinician access and home delivery through compounding pharmacy partners. Compounded medications are not FDA-approved finished drugs.
Strong fit
- Consumers focused on compounded weight-loss telehealth programs
- Patients comparing price and access for GLP-1 style compounded offerings
- Buyers who already understand compounded medications are not FDA-approved finished drugs
Weak fit
- Patients who want a broad multi-category DTC brand (hair, skin, sexual health) in one place
- Anyone unwilling to diligence pharmacy partners and physician network credentials
- Buyers looking for provider-side clinical software
Bottom line
Conditional: Henry Meds can fit consumers specifically shopping compounded weight-loss telehealth, with the same category-wide caveat that compounded medications are not FDA-approved products. Access and price positioning are the usual reasons patients look here. Product scope is narrower than longevity/peptide platforms like AgelessRx and Pepti in our framing. Diligence on the physician network and compounding pharmacy partners still belongs on the checklist. Pricing is relatively approachable for DTC but should be modeled through titration. Score reflects a solid niche fit with clearer limits than broader DTC platforms.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Conditional: Henry Meds can fit consumers specifically shopping compounded weight-loss telehealth, with the same category-wide caveat that compounded medications are not FDA-approved products. Access and price positioning are the usual reasons patients look here. Product scope is narrower than longevity/peptide platforms like AgelessRx and Pepti in our framing. Diligence on the physician network and compounding pharmacy partners still belongs on the checklist. Pricing is relatively approachable for DTC but should be modeled through titration. Score reflects a solid niche fit with clearer limits than broader DTC platforms.
Competitor landscape
| Vendor | Overall | Ease of use |
|---|---|---|
| Henry Meds | 6.7 | 6.3 |
| Pepti | 7.9 | 7.6 |
| AgelessRx | 7.3 | 7.0 |
Pricing
| Item | Detail |
|---|---|
| Model | Direct-to-consumer consult plus medication pricing, often membership-oriented. |
| What usually drives cost | Dose titration, shipping, and whether labs or follow-ups are bundled. |
| What to ask in diligence | All-in monthly cost at your expected dose, and which compounding pharmacy fills the prescription. |
| Published pricing | Vendor programs page lists flat monthly rates including medication, provider visits, supplies, and shipping — e.g. compounded injectable semaglutide $297/mo ($197–$247/mo effective on prepaid 12- and 6-month plans), liraglutide $179/mo, phentermine $149/mo, TRT from $129/mo, women’s HRT $149/mo (page last updated Dec 2025; checked Sep 2026). Confirm current quote. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get Henry Meds to function | |
| A primary focus on compounded weight-loss telehealth (GLP-1 style programs) | Henry Meds is narrower than multi-category DTC brands. |
| Understanding that compounded medications are not FDA-approved finished drugs | Conditional fit depends on accepting this category caveat. |
| Willingness to complete clinician review before medication fulfillment | Price shopping without consult completion does not produce a legitimate order. |
| Budget modeled through dose titration, not only the starter monthly rate | Titration changes all-in cost. |
| Comfort diligence-checking physician network and compounding pharmacy partners | Access and price are not substitutes for partner checks. |
| What will maximize your value | |
| Use published flat monthly program rates and confirm what is bundled (visits, supplies, shipping) | Bundling clarity is where DTC quotes get honest. |
| Ask which compounding pharmacy fills at your dose | Partner identity should be knowable before you commit. |
| Plan refill cadence after first shipment rather than one-off shopping | Weight-loss programs are ongoing; gaps break adherence. |
| Compare against peers only within compounded weight-loss telehealth | Broad longevity or peptide platforms are a different shop. |
| Revisit cost at expected maintenance dose | Starter pricing is a poor guide to month six. |
| Deal-breakers | |
| You want a broad multi-category DTC brand (hair, skin, sexual health) in one place. | |
| You are unwilling to diligence pharmacy partners and physician credentials. | |
| You need provider-side clinical software. | |
| You will only accept FDA-approved finished weight-loss drugs and refuse compounded options. | |
| You will not complete clinician review. | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Sign-up → clinician review | Typically 1–3 days after intake, depending on questionnaire completeness |
| 2 | Clinician review → medication ships | Often several days after approval, varying by pharmacy and product |
| 3 | First order → ongoing refill cadence | Monthly programs usually feel steady within 2–6 weeks once dose and shipping stabilize |
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category actually buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.